The inclusion of cancer in heart failure risk assessment tool for patients with type-2 diabetes mellitus: a precision medicine approach

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Narinder Kaur

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Design and rationale of the PERSEVERE study: a randomized controlled trial of large-bore mechanical thrombectomy versus the standard of care for high-risk pulmonary embolism

Professor N. Meneveau (Besancon, FR)

Abstract Slides Video

Presentation thumbnail

Patient-specific Display of Treatment Information and Adherence to Clinical Practice Guideline Recommendations (PEER-APP): a dual center, blinded randomized controlled trial

Doctor C. Scherer (Munich, DE)

Abstract Slides Video

Presentation thumbnail

Non-contact biometric system for detecting hypertension and diabetes using artificial intelligence and spectral imaging

Ms R. Uchida (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

Simplified regimen for the management of hypertension with telemedicine and blood pressure self-monitoring (SIMPLE): an open-label, multicenter, randomized controlled trial

Professor Y. Zhang (Shanghai, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Precision diagnostics to guide precision therapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Risk prediction and treatment options in cardio-oncology

Congress Session

Get out your crystal ball: predicting heart failure events using models

Congress Session

Daily cardiac problems in cancer patients

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources